Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TEGCOR: TEG-guided antiplatelet therapy in ACS
NCT01612884Phase 4Terminated
- Sponsor
- Indiana University
- Start
- Aug 2011
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of prasugrel in acute coronary syndrome (ACS) (2 arms), sponsored by Indiana University. Primary endpoint: Thrombelastography Maximum Amplitude at 1 day. Started Aug 2011; status: terminated.
02
Drugs
prasugrel
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT01612884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01612884.